| Year |
Citation |
Score |
| 2022 |
Takeshita M, Fukuyama H, Kamada K, Matsumoto T, Makino-Okamura C, Uchikubo-Kamo T, Tomabechi Y, Hanada K, Moriyama S, Takahashi Y, Ishigaki H, Nakayama M, Nguyen CT, Kitagawa Y, Itoh Y, et al. Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models. Iscience. 25: 105596. PMID 36406861 DOI: 10.1016/j.isci.2022.105596 |
0.384 |
|
| 2022 |
Shimojima M, Sugimoto S, Umekita K, Onodera T, Sano K, Tani H, Takamatsu Y, Yoshikawa T, Kurosu T, Suzuki T, Takahashi Y, Ebihara H, Saijo M. Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal Model. Viruses. 14. PMID 36016286 DOI: 10.3390/v14081665 |
0.372 |
|
| 2022 |
Seki Y, Yoshihara Y, Nojima K, Momose H, Fukushi S, Moriyama S, Wagatsuma A, Numata N, Sasaki K, Kuzuoka T, Yato Y, Takahashi Y, Maeda K, Suzuki T, Mizukami T, et al. Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants. Med (New York, N.Y.). 3: 406-421.e4. PMID 35815933 DOI: 10.1016/j.medj.2022.04.013 |
0.394 |
|
| 2022 |
Takano T, Morikawa M, Adachi Y, Kabasawa K, Sax N, Moriyama S, Sun L, Isogawa M, Nishiyama A, Onodera T, Terahara K, Tonouchi K, Nishimura M, Tomii K, Yamashita K, ... ... Takahashi Y, et al. Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine. Cell Reports. Medicine. 3: 100631. PMID 35545084 DOI: 10.1016/j.xcrm.2022.100631 |
0.427 |
|
| 2022 |
Shinada K, Sato T, Moriyama S, Adachi Y, Shinoda M, Ota S, Morikawa M, Mineshita M, Matsumura T, Takahashi Y, Shinkai M. Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir. Viruses. 14. PMID 35458400 DOI: 10.3390/v14040670 |
0.348 |
|
| 2022 |
Takeshita M, Nishina N, Moriyama S, Takahashi Y, Ishii M, Saya H, Kondo Y, Kaneko Y, Suzuki K, Fukunaga K, Takeuchi T. Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients. Clinical Immunology (Orlando, Fla.). 238: 108999. PMID 35398519 DOI: 10.1016/j.clim.2022.108999 |
0.369 |
|
| 2022 |
Miyamoto S, Arashiro T, Adachi Y, Moriyama S, Kinoshita H, Kanno T, Saito S, Katano H, Iida S, Ainai A, Kotaki R, Yamada S, Kuroda Y, Yamamoto T, Ishijima K, ... ... Takahashi Y, et al. Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants. Med (New York, N.Y.). 3: 249-261.e4. PMID 35261995 DOI: 10.1016/j.medj.2022.02.006 |
0.377 |
|
| 2022 |
Ishii H, Nomura T, Yamamoto H, Nishizawa M, Thu Hau TT, Harada S, Seki S, Nakamura-Hoshi M, Okazaki M, Daigen S, Kawana-Tachikawa A, Nagata N, Iwata-Yoshikawa N, Shiwa N, Suzuki T, ... ... Takahashi Y, et al. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8 T cell responses. Cell Reports. Medicine. 3: 100520. PMID 35233545 DOI: 10.1016/j.xcrm.2022.100520 |
0.453 |
|
| 2022 |
Kotaki R, Adachi Y, Moriyama S, Onodera T, Fukushi S, Nagakura T, Tonouchi K, Terahara K, Sun L, Takano T, Nishiyama A, Shinkai M, Oba K, Nakamura-Uchiyama F, Shimizu H, ... ... Takahashi Y, et al. SARS-CoV-2 Omicron-neutralizing memory B-cells are elicited by two doses of BNT162b2 mRNA vaccine. Science Immunology. eabn8590. PMID 35113654 DOI: 10.1126/sciimmunol.abn8590 |
0.467 |
|
| 2022 |
Fujigaki H, Yamamoto Y, Koseki T, Banno S, Ando T, Ito H, Fujita T, Naruse H, Hata T, Moriyama S, Takahashi Y, Suzuki T, Murakami T, Yoshida Y, Yagura Y, et al. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2. Microbiology Spectrum. e0118121. PMID 35044205 DOI: 10.1128/spectrum.01181-21 |
0.449 |
|
| 2021 |
Shinnakasu R, Sakakibara S, Yamamoto H, Wang PH, Moriyama S, Sax N, Ono C, Yamanaka A, Adachi Y, Onodera T, Sato T, Shinkai M, Suzuki R, Matsuura Y, Hashii N, ... Takahashi Y, et al. Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses. The Journal of Experimental Medicine. 218. PMID 34623376 DOI: 10.1084/jem.20211003 |
0.462 |
|
| 2021 |
Onodera T, Kita S, Adachi Y, Moriyama S, Sato A, Nomura T, Sakakibara S, Inoue T, Tadokoro T, Anraku Y, Yumoto K, Tian C, Fukuhara H, Sasaki M, Orba Y, ... ... Takahashi Y, et al. A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site. Immunity. PMID 34508662 DOI: 10.1016/j.immuni.2021.08.025 |
0.418 |
|
| 2021 |
Moriyama S, Adachi Y, Sato T, Tonouchi K, Sun L, Fukushi S, Yamada S, Kinoshita H, Nojima K, Kanno T, Tobiume M, Ishijima K, Kuroda Y, Park ES, Onodera T, ... ... Takahashi Y, et al. Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants. Immunity. PMID 34246326 DOI: 10.1016/j.immuni.2021.06.015 |
0.403 |
|
| 2021 |
Fujigaki H, Inaba M, Osawa M, Moriyama S, Takahashi Y, Suzuki T, Yamase K, Yoshida Y, Yagura Y, Oyamada T, Takemura M, Doi Y, Saito K. Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients. Journal of Immunology (Baltimore, Md. : 1950). 206: 2393-2401. PMID 33941657 DOI: 10.4049/jimmunol.2001369 |
0.311 |
|
| 2021 |
Uemura K, Sasaki M, Sanaki T, Toba S, Takahashi Y, Orba Y, Hall WW, Maenaka K, Sawa H, Sato A. MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2. Scientific Reports. 11: 5376. PMID 33686154 DOI: 10.1038/s41598-021-84882-7 |
0.316 |
|
| 2021 |
Takeshita M, Nishina N, Moriyama S, Takahashi Y, Uwamino Y, Nagata M, Aoki W, Masaki K, Ishii M, Saya H, Kondo Y, Kaneko Y, Suzuki K, Fukunaga K, Takeuchi T, et al. Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan. Virology. 555: 35-43. PMID 33450669 DOI: 10.1016/j.virol.2020.12.020 |
0.361 |
|
| 2021 |
Sano K, Saito S, Suzuki T, Kotani O, Ainai A, van Riet E, Tabata K, Saito K, Takahashi Y, Yokoyama M, Sato H, Maruno T, Usami K, Uchiyama S, Ogawa-Goto K, et al. An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody. Plos One. 16: e0245244. PMID 33412571 DOI: 10.1371/journal.pone.0245244 |
0.402 |
|
| 2021 |
Kuraoka M, Adachi Y, Takahashi Y. Hide and seek: interplay between influenza viruses and B cells. International Immunology. 32: 605-611. PMID 32304215 DOI: 10.1093/intimm/dxaa028 |
0.593 |
|
| 2020 |
Yato K, Onodera T, Matsuda M, Moriyama S, Fujimoto A, Watashi K, Aizaki H, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Tamura K, Takahashi Y, Wakita T, Muramatsu M, et al. Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1. Journal of Virology. PMID 33298539 DOI: 10.1128/JVI.01680-20 |
0.447 |
|
| 2020 |
Sugimoto-Ishige A, Harada M, Tanaka M, Terooatea T, Adachi Y, Takahashi Y, Tanaka T, Burrows PD, Hikida M, Takemori T. Bim establishes the B cell repertoire from early to late in the immune response. International Immunology. PMID 32889526 DOI: 10.1093/Intimm/Dxaa060 |
0.392 |
|
| 2020 |
Tonouchi K, Adachi Y, Moriyama S, Sano K, Tabata K, Ide K, Takeyama H, Suzuki T, Takahashi Y. Stereotyped B-cell response that counteracts antigenic variation of influenza viruses. International Immunology. PMID 32504541 DOI: 10.1093/intimm/dxaa038 |
0.455 |
|
| 2020 |
De Groot AS, Moise L, Terry F, Gutierrez AH, Hindocha P, Richard G, Hoft DF, Ross TM, Noe AR, Takahashi Y, Kotraiah V, Silk SE, Nielsen CM, Minassian AM, Ashfield R, et al. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. Frontiers in Immunology. 11: 442. PMID 32318055 DOI: 10.3389/Fimmu.2020.00442 |
0.445 |
|
| 2020 |
Saenwongsa W, Nithichanon A, Chittaganpitch M, Buayai K, Kewcharoenwong C, Thumrongwilainet B, Butta P, Palaga T, Takahashi Y, Ato M, Lertmemongkolchai G. Metformin-induced suppression of IFN-α via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes. Scientific Reports. 10: 3229. PMID 32094377 DOI: 10.1038/S41598-020-60213-0 |
0.49 |
|
| 2019 |
Onodera T, Hashi K, Shukla RK, Miki M, Takai-Todaka R, Fujimoto A, Kuraoka M, Miyoshi T, Kobayashi K, Hasegawa H, Ato M, Kelsoe G, Katayama K, Takahashi Y. Immune-Focusing Properties of Virus-like Particles Improve Protective IgA Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 31704880 DOI: 10.4049/Jimmunol.1900481 |
0.709 |
|
| 2019 |
Wada Y, Nithichanon A, Nobusawa E, Moise L, Martin WD, Yamamoto N, Terahara K, Hagiwara H, Odagiri T, Tashiro M, Lertmemongkolchai G, Takeyama H, De Groot AS, Ato M, Takahashi Y. Publisher Correction: A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines. Scientific Reports. 9: 14730. PMID 31594990 DOI: 10.1038/S41598-019-50828-3 |
0.323 |
|
| 2019 |
Adachi Y, Tonouchi K, Nithichanon A, Kuraoka M, Watanabe A, Shinnakasu R, Asanuma H, Ainai A, Ohmi Y, Yamamoto T, Ishii KJ, Hasegawa H, Takeyama H, Lertmemongkolchai G, Kurosaki T, ... ... Takahashi Y, et al. Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies. Nature Communications. 10: 3883. PMID 31462639 DOI: 10.1038/S41467-019-11821-6 |
0.72 |
|
| 2019 |
Leach S, Shinnakasu R, Adachi Y, Momota M, Makino-Okamura C, Yamamoto T, Ishii KJ, Fukuyama H, Takahashi Y, Kurosaki T. Requirement for memory B cell activation in protection from heterologous influenza virus reinfection. International Immunology. PMID 31231764 DOI: 10.1093/intimm/dxz049 |
0.43 |
|
| 2019 |
Bajic G, Maron MJ, Adachi Y, Onodera T, McCarthy KR, McGee CE, Sempowski GD, Takahashi Y, Kelsoe G, Kuraoka M, Schmidt AG. Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope. Cell Host & Microbe. PMID 31104946 DOI: 10.1016/J.Chom.2019.04.003 |
0.729 |
|
| 2019 |
Watanabe A, McCarthy KR, Kuraoka M, Schmidt AG, Adachi Y, Onodera T, Tonouchi K, Caradonna TM, Bajic G, Song S, McGee CE, Sempowski GD, Feng F, Urick P, Kepler TB, ... Takahashi Y, et al. Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism. Cell. 177: 1124-1135.e16. PMID 31100267 DOI: 10.1016/J.Cell.2019.03.048 |
0.733 |
|
| 2019 |
Sun L, Kono N, Toh H, Xue H, Sano K, Suzuki T, Ainai A, Orba Y, Yamagishi J, Hasegawa H, Takahashi Y, Itamura S, Ohnishi K. Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing. Journal of Visualized Experiments : Jove. PMID 30933062 DOI: 10.3791/58804 |
0.383 |
|
| 2018 |
Yamamoto T, Masuta Y, Momota M, Kanekiyo M, Kanuma T, Takahama S, Moriishi E, Yasutomi Y, Saito T, Graham BS, Takahashi Y, Ishii KJ. A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection. International Immunology. PMID 30535055 DOI: 10.1093/Intimm/Dxy069 |
0.504 |
|
| 2017 |
Wada Y, Nithichanon A, Nobusawa E, Moise L, Martin WD, Yamamoto N, Terahara K, Hagiwara H, Odagiri T, Tashiro M, Lertmemongkolchai G, Takeyama H, Groot AS, Ato M, Takahashi Y. A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines. Scientific Reports. 7: 1283. PMID 28455520 DOI: 10.1038/S41598-017-01372-5 |
0.417 |
|
| 2017 |
Takahashi Y, Kelsoe G. Role of germinal centers for the induction of broadly-reactive memory B cells. Current Opinion in Immunology. 45: 119-125. PMID 28355576 DOI: 10.1016/J.Coi.2017.03.002 |
0.606 |
|
| 2016 |
Miyauchi K, Sugimoto-Ishige A, Harada Y, Adachi Y, Usami Y, Kaji T, Inoue K, Hasegawa H, Watanabe T, Hijikata A, Fukuyama S, Maemura T, Okada-Hatakeyama M, Ohara O, Kawaoka Y, ... Takahashi Y, et al. Protective neutralizing influenza antibody response in the absence of T follicular helper cells. Nature Immunology. PMID 27798619 DOI: 10.1038/Ni.3563 |
0.553 |
|
| 2016 |
Onodera T, Hosono A, Odagiri T, Tashiro M, Kaminogawa S, Okuno Y, Kurosaki T, Ato M, Kobayashi K, Takahashi Y. Whole-Virion Influenza Vaccine Recalls an Early Burst of High-Affinity Memory B Cell Response through TLR Signaling. Journal of Immunology (Baltimore, Md. : 1950). PMID 27053762 DOI: 10.4049/jimmunol.1600046 |
0.421 |
|
| 2016 |
Li Y, Takahashi Y, Fujii S, Zhou Y, Hong R, Suzuki A, Tsubata T, Hase K, Wang JY. EAF2 mediates germinal centre B-cell apoptosis to suppress excessive immune responses and prevent autoimmunity. Nature Communications. 7: 10836. PMID 26935903 DOI: 10.1038/ncomms10836 |
0.381 |
|
| 2015 |
Adachi Y, Onodera T, Yamada Y, Daio R, Tsuiji M, Inoue T, Kobayashi K, Kurosaki T, Ato M, Takahashi Y. Distinct germinal center selection at local sites shapes memory B cell response to viral escape. The Journal of Experimental Medicine. 212: 1709-23. PMID 26324444 DOI: 10.1084/jem.20142284 |
0.391 |
|
| 2014 |
Matsuzaki Y, Sugawara K, Nakauchi M, Takahashi Y, Onodera T, Tsunetsugu-Yokota Y, Matsumura T, Ato M, Kobayashi K, Shimotai Y, Mizuta K, Hongo S, Tashiro M, Nobusawa E. Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants. Journal of Virology. 88: 12364-73. PMID 25122788 DOI: 10.1128/JVI.01381-14 |
0.43 |
|
| 2014 |
Takemori T, Kaji T, Takahashi Y, Shimoda M, Rajewsky K. Generation of memory B cells inside and outside germinal centers European Journal of Immunology. 44: 1258-1264. PMID 24610726 DOI: 10.1002/Eji.201343716 |
0.431 |
|
| 2014 |
Kikuchi Y, Kunitoh-Asari A, Hayakawa K, Imai S, Kasuya K, Abe K, Adachi Y, Fukudome S, Takahashi Y, Hachimura S. Oral administration of Lactobacillus plantarum strain AYA enhances IgA secretion and provides survival protection against influenza virus infection in mice. Plos One. 9: e86416. PMID 24466081 DOI: 10.1371/journal.pone.0086416 |
0.318 |
|
| 2013 |
Ato M, Takahashi Y, Fujii H, Hashimoto S, Kaji T, Itamura S, Horiuchi Y, Arakawa Y, Tashiro M, Takemori T. Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis. Vaccine. 31: 2184-90. PMID 23434386 DOI: 10.1016/j.vaccine.2013.02.016 |
0.339 |
|
| 2012 |
Kaji T, Ishige A, Hikida M, Taka J, Hijikata A, Kubo M, Nagashima T, Takahashi Y, Kurosaki T, Okada M, Ohara O, Rajewsky K, Takemori T. Distinct cellular pathways select germlineencoded and somatically mutated antibodies into immunological memory Journal of Experimental Medicine. 209: 2079-2097. PMID 23027924 DOI: 10.1084/Jem.20120127 |
0.515 |
|
| 2012 |
Takahashi Y, Onodera T, Kobayashi K, Kurosaki T. Primary and secondary B-cell responses to pulmonary virus infection. Infectious Disorders Drug Targets. 12: 232-40. PMID 22394179 DOI: 10.2174/187152612800564400 |
0.384 |
|
| 2012 |
Onodera T, Takahashi Y, Yokoi Y, Ato M, Kodama Y, Hachimura S, Kurosaki T, Kobayashi K. Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection. Proceedings of the National Academy of Sciences of the United States of America. 109: 2485-90. PMID 22308386 DOI: 10.1073/pnas.1115369109 |
0.376 |
|
| 2012 |
Ohnishi K, Takahashi Y, Kono N, Nakajima N, Mizukoshi F, Misawa S, Yamamoto T, Mitsuki YY, Fu S, Hirayama N, Ohshima M, Ato M, Kageyama T, Odagiri T, Tashiro M, et al. Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus. Japanese Journal of Infectious Diseases. 65: 19-27. PMID 22274153 |
0.441 |
|
| 2012 |
Yuki N, Takahashi Y, Ihara T, Ito S, Nakajima T, Funakoshi K, Furukawa K, Kobayashi K, Odaka M. Lack of antibody response to Guillain-Barré syndrome-related gangliosides in mice and men after novel flu vaccination. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 116-7. PMID 21084265 DOI: 10.1136/jnnp.2010.227777 |
0.424 |
|
| 2011 |
Harada Y, Ninomiya-Mori A, Takahashi Y, Shirakura M, Kishida N, Kageyama T, Tada Y, Tashiro M, Odagiri T. Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice. Vaccine. 29: 8330-7. PMID 21911027 DOI: 10.1016/j.vaccine.2011.08.091 |
0.433 |
|
| 2010 |
Kurosaki T, Aiba Y, Kometani K, Moriyama S, Takahashi Y. Unique properties of memory B cells of different isotypes. Immunological Reviews. 237: 104-16. PMID 20727032 DOI: 10.1111/j.1600-065X.2010.00939.x |
0.343 |
|
| 2009 |
Takahashi Y, Hasegawa H, Hara Y, Ato M, Ninomiya A, Takagi H, Odagiri T, Sata T, Tashiro M, Kobayashi K. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice. The Journal of Infectious Diseases. 199: 1629-37. PMID 19385735 DOI: 10.1086/598954 |
0.536 |
|
| 2007 |
Tsunetsugu-Yokota Y, Ato M, Takahashi Y, Hashimoto SI, Kaji T, Kuraoka M, Yamamoto KI, Mitsuki YY, Yamamoto T, Oshima M, Ohnishi K, Takemori T. Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responses Japanese Journal of Infectious Diseases. 60: 106-112. PMID 17515642 |
0.697 |
|
| 2004 |
Takasuka N, Fujii H, Takahashi Y, Kasai M, Morikawa S, Itamura S, Ishii K, Sakaguchi M, Ohnishi K, Ohshima M, Hashimoto S, Odagiri T, Tashiro M, Yoshikura H, Takemori T, et al. A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. International Immunology. 16: 1423-30. PMID 15314040 DOI: 10.1093/intimm/dxh143 |
0.519 |
|
| 2004 |
Yoshizawa I, Mizuochi T, Ogata A, Murakami M, Yagita H, Takahashi Y, Mizuochi T, Takemori T, Tsunetsugu-Yokota Y, Yagaita H. Studies on the generation and maintenance of mucosal cytotoxic T lymphocytes against human immunodeficiency virus type 1 Gag in mice. Aids Research and Human Retroviruses. 19: 469-79. PMID 12882656 DOI: 10.1089/088922203766774513 |
0.351 |
|
| 2003 |
Inouye K, Ito T, Fujimaki H, Takahashi Y, Takemori T, Pan X, Tohyama C, Nohara K. Suppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the high-affinity antibody response in C57BL/6 mice. Toxicological Sciences : An Official Journal of the Society of Toxicology. 74: 315-24. PMID 12773764 DOI: 10.1093/toxsci/kfg132 |
0.403 |
|
| 2002 |
Toyama H, Okada S, Hatano M, Takahashi Y, Takeda N, Ichii H, Takemori T, Kuroda Y, Tokuhisa T. Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells. Immunity. 17: 329-39. PMID 12354385 DOI: 10.1016/S1074-7613(02)00387-4 |
0.306 |
|
| Show low-probability matches. |